Hanaa Badran

Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria

Christophe Duvoux, Françoise Roudot‐Thoraval, Thomas Decaens et al. · Gastroenterology · 2012 · 941 citations · Full text

Medicine, Oncology, Pathology +13

Response of Hepatitis C Genotype-4 Naive Patients to 24 Weeks of Peg-Interferon-alpha2b/Ribavirin or Induction-Dose Interferon-alpha2b/Ribavirin/Amantadine: A Non-Randomized Controlled Study

Abdel‐Rahman El‐Zayadi, Mohy Attia, Eman Barakat et al. · The American Journal of Gastroenterology · 2005 · 82 citations

Pharmacy, Internal Medicine, Pharmacotherapy +15

Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma

Thomas Decaens, Françoise Roudot‐Thoraval, Hanaa Badran et al. · Liver International · 2011 · 54 citations

Medicine, Biostatistics, Oncology +17

Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients.

Abdel‐Rahman El‐Zayadi, O Selim, S Haddad et al. · PubMed · 1999 · 41 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of surveillance for hepatocellular carcinoma on tumor staging and treatment decisions in Egyptian patients

Abdel‐Rahman El‐Zayadi, Hanaa Badran, Sherine Shawky et al. · Hepatology International · 2010 · 34 citations · Full text

Medicine, Oncology, Surgery +13